New Data
September 27, 2023
Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US
The ImpriMed Personalized Prediction Profile for dogs with lymphoid malignancies provides clinical outcome predictions for different chemotherapy treatment options.
Read More →